%0 Figure %A Koppitz, Martin %A Eschenburg, Charlotte %A Salzmann, Emilia %A Rosewich, Martin %A Schubert, Ralf %A Zielen, Stefan %D 2016 %T Sputum weight and cells comparing smokers and non-smokers during treatment with Tyloxapol and saline. %U https://plos.figshare.com/articles/figure/Sputum_weight_and_cells_comparing_smokers_and_non-smokers_during_treatment_with_Tyloxapol_and_saline_/3449252 %R 10.1371/journal.pone.0156999.g004 %2 https://ndownloader.figshare.com/files/5415344 %K saline treatment %K RV %K 3 weeks %K endpoint sputum weight %K patients inhaled Tyloxapol %K Tyloxapol treatment %K FVC %K AE %K Chronic Obstructive Pulmonary Disease %K IL %K CI %K FEV %K lung function parameters %K COPD %K Randomized Controlled Trial Objective Mucoactive drugs %K NCT %X

(A, C and E) represent the Tyloxapol group, and (B, D and F) represent the saline group. (A-B) Sputum weight before processing. (C-D) the total cells and (E-F) the neutrophils. Sample size: A: n = 36 vs. 20, B: n = 33 vs. 18, C: n = 24 vs. 13, D: n = 22 vs. 12, E: n = 23 vs. 11, F: n = 22 vs. 9. Graphs show the pooled patients at all 3 visits and are separated by smoking status. Bars represent the median. ** p < 0.01; p-values were calculated using the Mann-Whitney test.

%I PLOS ONE